Quick Comparison

Kojic AcidLactic Acid
Typical ConcentrationConcentrations: 1-4%. Kojic dipalmitate is a more stable ester form but less potent. Apply once or twice daily. Often combined with other brightening agents (arbutin, vitamin C, niacinamide). Results visible at 4-8 weeks.Concentrations: 5-12% for daily use. 30-50% for professional peels. Start with 5% every other night. The Ordinary offers 5% (gentle) and 10% (moderate) options. Always use SPF during the day.
ApplicationTopical (serum, cream). Store in airtight, opaque packaging. Discard if the product turns brown.Topical (serum, peel, toner). Apply to dry skin at night. Follow with moisturizer.
Research Papers10 papers10 papers
Categories

Mechanism of Action

Kojic Acid

Kojic acid (5-hydroxy-2-hydroxymethyl-4H-pyran-4-one) inhibits tyrosinase through copper chelation—tyrosinase is a type-3 copper enzyme requiring two copper ions to catalyze tyrosine to L-DOPA and L-DOPA to dopaquinone. By sequestering copper, kojic acid renders tyrosinase inactive. May also inhibit tyrosinase-related protein-1 (TRP-1). Exhibits direct antioxidant activity, scavenging superoxide and hydroxyl radicals. Relatively unstable—oxidizes with air and light, forming brown degradation products that lose activity; opaque, airtight packaging and low pH improve stability. Kojic dipalmitate is a more stable ester but requires enzymatic cleavage, reducing potency. Contact sensitization can develop with prolonged use.

Lactic Acid

Lactic acid (90 Da, larger than glycolic acid) exfoliates via the standard AHA mechanism: chelating calcium at corneodesmosomes and promoting desquamation through protease activation. Unlike glycolic acid, lactic acid is a natural component of the skin's natural moisturizing factor (NMF) and functions as a humectant, drawing water into the stratum corneum through hygroscopic binding. It inhibits tyrosinase enzyme activity in melanocytes, providing mild brightening. At higher concentrations (10%+), lactic acid upregulates serine palmitoyltransferase and glucosylceramide synthase in keratinocytes, stimulating ceramide synthesis and improving barrier lipid composition. It also enhances filaggrin proteolysis to NMF components. This dual action—exfoliation plus barrier support—makes it the most moisturizing AHA and clinically useful for dry, sensitive, or barrier-compromised skin.

Risks & Safety

Kojic Acid

Common

Contact sensitization (developing an allergy over time with repeated use), redness, irritation.

Serious

Contact dermatitis in sensitized individuals.

Rare

Paradoxical darkening in very sensitive skin types.

Lactic Acid

Common

Mild stinging, redness — less than glycolic acid at equivalent concentrations. Sun sensitivity.

Serious

None at cosmetic concentrations.

Rare

Over-exfoliation with daily high-concentration use.

Full Profiles